Ken Griffin Corbus Pharmaceuticals Holdings, Inc. Put Options Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
Put Options
1 transactions
Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0-
Kingsbury Capital Investment Advisors LLC Evanston, IL33.7KShares$409,4550.01% of portfolio
-
Exane Derivatives2.65KShares$32,1970.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.31KShares$28,0900.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,268,000
- Market Cap $1.52B
- Description
- Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...